Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
GATA1	"ERYF1, GATA-1, GF1, NF-E1, NFE1"	ENSG00000102145	"GATA binding protein 1"	P15976	X	48786554-48794311	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"blood: 78.3;bone marrow: 37.0"	"Group enriched"	"Detected in some"	9	"HEL: 49.6;HMC-1: 51.2;K-562: 52.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 78.3"	"Lineage enriched"	"Detected in single"	784	"granulocytes: 78.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000232, HPA000233, CAB009195"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB009195: AB_2232148, HPA000232: AB_1078949, HPA000233: AB_1078951"	"unprognostic (1.93e-1)"	"unprognostic (7.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.00e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.04e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.71e-2)"	0.7	0.2	0.1	2.4	0.7	37.0	0.3	0.0	0.3	0.7	0.3	0.0	0.0	0.6	4.9	2.4	0.4	0.3	0.6	2.3	0.1	0.3	0.4	0.8	5.6	0.2	0.6	0.0	0.1	0.1	0.1	0.5	2.8	0.3	1.4	0.4	1.6	0.3	0.2	0.1	0.6	0.8	2.4	0.3	4.9	0.5	3.1	0.0	1.5	0.6	1.1	0.6	0.9	0.6	0.0	0.0	78.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.6	0.0	0.0	0.0	0.0	51.2	0.0	0.0	0.0	0.0	0.0	52.8	0.1	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	78.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.1	0.7	0.0	0.3	0.1	0.3	0.6	0.0	0.3	0.0
CEBPE	CRP1	ENSG00000092067	"CCAAT/enhancer binding protein epsilon"	Q15744	14	23117304-23119616	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 87.1;bone marrow: 29.4"	"Group enriched"	"Detected in some"	4	"HL-60: 58.0;NB-4: 30.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	201	"eosinophil: 87.1"	"Lineage enriched"	"Detected in single"	237	"granulocytes: 87.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002928, CAB005113"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB005113: AB_631240, HPA002928: AB_1078494"	"unprognostic (1.33e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.57e-2)"	"unprognostic (8.19e-2)"	0.3	0.0	0.1	0.8	0.2	29.4	0.1	0.1	1.3	0.1	0.1	0.1	0.1	1.4	0.1	0.1	0.1	0.3	0.1	2.2	0.1	0.1	0.1	0.2	2.7	0.2	0.3	0.1	0.1	0.1	0.0	0.1	2.2	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	1.9	0.1	0.3	7.7	0.4	0.1	0.1	2.6	0.1	0.1	0.8	0.2	0.1	0.0	0.1	87.1	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	30.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.3	87.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.1	1.3	0.1	0.1	0.3	0.1	0.1	0.1
PRSS33	EOS	ENSG00000103355	"Serine protease 33"	Q8NF86	16	2783953-2787948	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"blood: 132.7"	"Group enriched"	"Detected in some"	9	"HMC-1: 5.1;SK-MEL-30: 10.4;U-2 OS: 3.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	78	"eosinophil: 132.7"	"Lineage enriched"	"Detected in single"	422	"granulocytes: 132.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"						"unprognostic (4.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.86e-2)"		"unprognostic (1.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.42e-2)"			"unprognostic (2.28e-1)"	"unprognostic (1.91e-1)"		"unprognostic (2.70e-2)"	0.0	0.0	0.3	1.1	0.3	0.1	0.1	0.2	0.4	0.2	0.2	0.2	0.0	0.8	0.1	0.0	0.1	10.2	3.6	0.0	0.1	0.1	0.3	0.0	0.2	1.1	0.1	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.2	22.5	1.9	0.0	0.0	0.0	1.8	0.8	0.0	0.7	1.1	0.9	0.2	0.2	0.2	1.0	0.2	1.0	0.0	0.0	0.0	132.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	10.4	0.0	0.0	0.0	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.1	0.1	0.1	0.0	0.0	0.2
CHST13	C4ST3	ENSG00000180767	"Carbohydrate sulfotransferase 13"	Q8NET6	3	126524283-126543291	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 46.8;liver: 42.5"	"Group enriched"	"Detected in some"	8	"CACO-2: 12.2;Hep G2: 21.9;NB-4: 14.6;THP-1: 8.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"eosinophil: 46.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 46.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"						"unprognostic (5.68e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.42e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.45e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.75e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-2)"	0.5	0.2	0.2	0.5	0.3	0.9	0.0	0.2	0.6	0.1	0.9	0.1	0.0	0.8	0.0	1.1	0.1	0.1	0.2	1.1	0.2	0.1	2.6	42.5	0.6	0.6	0.3	0.2	0.4	0.0	0.0	0.0	0.4	0.4	0.2	0.2	0.6	0.5	0.1	0.3	0.0	1.8	0.0	0.3	2.9	0.6	9.7	0.1	0.5	0.1	0.0	0.2	0.1	0.0	0.0	7.0	46.8	10.6	0.0	0.0	3.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.2	21.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	10.6	46.8	0.0	6.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	9.8	0.0	5.2	0.0	0.0	3.6	0.2	0.3	0.2	0.6	0.2	0.1	0.3	0.2	0.4	0.1
FAM9C	TEX39C	ENSG00000187268	"Family with sequence similarity 9 member C"	Q8IZT9	X	13035618-13044682	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 29.8;testis: 12.0"	"Cell line enriched"	"Detected in some"	55	"AN3-CA: 63.6"	"Cancer enriched"	"Detected in single"	22	"testis cancer: 4.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"eosinophil: 3.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 3.0"																				"unprognostic (2.28e-1)"				"unprognostic (7.35e-2)"			"unprognostic (1.90e-1)"		"unprognostic (1.66e-1)"	"unprognostic (3.35e-2)"		"unprognostic (2.06e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"		0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	1.3	0.0	2.0	0.0	0.1	0.0	0.1	29.8	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.0	0.1	0.0	0.3	0.0	0.1	0.1	0.3	63.6	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.5	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.5	0.0	0.6	0.0	0.2	0.5	0.0	0.0	0.3	0.3	0.1	0.5	0.0	0.2	0.4	0.2	0.3	0.2	0.2	1.1	0.2	0.1	0.3	0.4	0.2	0.1	0.3	0.0	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
GAPT	"C5orf29, FLJ33641"	ENSG00000175857	"GRB2 binding adaptor protein, transmembrane"	Q8N292	5	58491435-58497090	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 117.8"	"Cell line enhanced"	"Detected in some"		"HEL: 26.8;HL-60: 15.5;NB-4: 16.1;THP-1: 12.7;U-937: 44.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 117.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 117.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011070	Uncertain									"HPA011070: AB_1848887"	"unprognostic (9.79e-2)"	"unprognostic (5.67e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.36e-2)"	"unprognostic (8.09e-4)"	"unprognostic (4.32e-1)"	"unprognostic (1.23e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.47e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.52e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-2)"	1.4	0.8	1.4	15.5	2.7	8.5	1.0	0.6	1.2	1.8	1.4	1.6	0.4	1.8	1.3	2.2	3.3	1.2	3.1	1.1	1.5	1.7	1.6	1.0	7.2	19.4	4.5	0.9	0.7	1.2	0.0	1.5	0.8	4.4	2.6	2.0	1.4	2.3	0.4	0.5	0.9	8.2	2.4	5.9	25.8	1.7	0.8	3.2	5.2	1.1	0.5	23.5	5.1	1.2	12.0	25.4	117.8	8.2	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0	15.5	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	16.1	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.6	0.0	12.3	8.2	117.8	0.0	5.7	0.0	12.0	0.0	0.0	9.4	11.9	0.0	0.0	10.1	0.1	6.6	25.4	0.0	3.4	1.4	2.7	0.6	1.2	1.5	1.7	4.5	0.9	4.4	3.2
LGALS12	GRIP1	ENSG00000133317	"Galectin 12"	Q96DT0	11	63506084-63516774	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 45.1;blood: 90.2;breast: 28.6"	"Group enriched"	"Detected in some"	14	"ASC diff: 11.6;HL-60: 19.9;NB-4: 39.2;U-937: 42.1"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"basal ganglia: 1.1"	"Cell type enriched"	"Detected in some"	19	"eosinophil: 90.2"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 90.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (3.89e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.26e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavourable (4.60e-7)"	"unprognostic (2.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.22e-2)"	"unprognostic (8.60e-2)"	45.1	0.5	0.1	5.8	1.1	10.1	28.6	0.0	0.1	0.1	10.6	0.0	0.0	0.3	0.2	1.1	0.1	0.7	7.7	2.2	0.1	0.1	0.4	0.2	1.4	5.3	0.1	0.0	0.5	0.5	0.0	0.1	0.1	0.2	0.7	0.4	0.1	5.9	1.6	1.6	0.6	1.4	0.6	0.2	0.8	0.4	0.1	0.0	0.1	0.5	2.4	0.2	0.9	0.2	0.0	1.2	90.2	4.7	0.0	0.0	2.8	0.0	0.0	0.0	0.0	11.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	19.9	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	42.1	0.0	1.8	4.7	90.2	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	2.8	0.1	1.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0
VSTM1	UNQ3033	ENSG00000189068	"V-set and transmembrane domain containing 1"	Q6UX27	19	54040825-54063953	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 53.5;bone marrow: 39.4"	"Group enriched"	"Detected in some"	7	"EFO-21: 1.0;HMC-1: 2.5;hTERT-HME1: 3.9;U-2 OS: 3.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	15	"eosinophil: 53.5"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 53.5"									HPA059365			Approved	Vesicles	"Secreted to blood"			Vesicles		"HPA059365: "	"unprognostic (5.13e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.30e-1)"		"unprognostic (1.09e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-5)"	"unprognostic (3.73e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.67e-2)"	0.9	0.2	0.7	0.1	0.2	39.4	0.1	0.0	0.5	0.2	0.1	1.3	0.0	0.1	0.3	0.1	0.1	0.6	0.1	4.2	0.7	0.2	0.5	1.2	4.0	7.2	0.6	0.0	0.2	1.1	0.1	8.7	2.0	0.2	0.1	0.1	0.2	0.1	0.1	2.1	0.1	0.8	0.3	0.1	7.9	0.1	0.5	0.3	3.0	0.4	0.0	0.1	0.8	0.0	0.0	0.0	53.5	3.6	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.0	53.5	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.6	0.0	0.0	2.1	0.7	0.2	0.0	0.5	0.7	0.2	0.6	0.0	0.2	0.3
ADORA3	AD026	ENSG00000282608	"Adenosine A3 receptor"	P0DMS8	1	111499429-111503760	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 88.6;brain: 25.5"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 47.5"									"Cell type enriched"	"Detected in some"	40	"eosinophil: 88.6"	"Lineage enriched"	"Detected in many"	40	"granulocytes: 88.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"																															5.2	13.4	8.7	3.1	12.0	0.0	4.5	1.0	6.7	3.7	5.2	10.3	0.0	3.5	0.5	1.0	1.8	2.8	4.8	1.6	7.5		1.9	2.1	2.8	3.8	17.7	2.2	1.2	1.0	0.9	1.2	2.0	12.1	1.0	4.2	2.7	1.1	1.9	0.5	0.0	7.9	3.8	25.5	1.5	2.2	1.1	13.3	0.4	0.5	0.0	1.9	3.4	0.0	0.0	2.2	88.6	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	47.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	88.6	0.0	0.7	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.3	0.4	0.0	0.3										
PRSS41	TESSP1	ENSG00000215148	"Serine protease 41"	Q7RTY9	16	2798485-2805302	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 11.6;testis: 4.0"	"Cell line enriched"	"Detected in single"	11	"BEWO: 6.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"					"Cell type enriched"	"Detected in single"	116	"eosinophil: 11.6"	"Lineage enriched"	"Detected in single"	116	"granulocytes: 11.6"																						"unprognostic (1.58e-1)"	"unprognostic (3.65e-1)"		"unprognostic (3.04e-3)"				"unprognostic (1.03e-1)"	"unprognostic (1.71e-2)"			"unprognostic (1.69e-1)"	"unprognostic (1.98e-1)"		"unprognostic (1.24e-2)"	0.0	0.0		0.1		0.0	0.1		0.0	0.0	0.1			0.0	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		1.7	0.0	0.0	0.0	0.1	0.0		0.0	1.2	4.0			0.0		0.0	0.0		0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SIGLEC8	"MGC59785, SAF2, SIGLEC-8, SIGLEC8L"	ENSG00000105366	"Sialic acid binding Ig like lectin 8"	Q9NYZ4	19	51450847-51458456	"CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 63.0"	"Cell line enriched"	"Detected in some"	45	"HMC-1: 57.4"	"Cancer enhanced"	"Detected in many"		"glioma: 7.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	42	"eosinophil: 63.0"	"Lineage enriched"	"Detected in single"	623	"granulocytes: 63.0"									HPA012556	Uncertain		Uncertain	Cytosol				Cytosol		"HPA012556: AB_1856869"	"unprognostic (1.27e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.19e-1)"	"unprognostic (8.62e-3)"	"unprognostic (7.18e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.28e-3)"	"unprognostic (3.29e-1)"	0.6	6.7	5.8	2.4	8.4	0.7	2.3	0.7	7.0	1.4	2.9	7.4	0.0	2.9	1.0	1.1	1.1	1.1	2.7	0.3	8.6	4.8	0.4	1.6	4.1	9.6	8.3	3.6	0.3	0.7	0.7	1.2	0.1	7.5	1.0	2.8	0.1	1.1	0.9	0.3	0.8	4.5	1.5	14.8	9.2	2.1	0.5	6.2	0.6	0.7	0.0	4.1	2.0	0.7	0.0	0.0	63.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	57.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.5	0.1	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.8	8.4	0.7	5.6	8.6	4.8	8.3	3.6	7.5	6.2
ALOX15	15-LOX-1	ENSG00000161905	"Arachidonate 15-lipoxygenase"	P16050	17	4630902-4642294	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 27.9;blood: 89.8;lung: 24.4"	"Group enriched"	"Detected in some"	7	"HMC-1: 16.1;MCF7: 14.0;T-47d: 4.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	183	"eosinophil: 89.8"	"Lineage enriched"	"Detected in single"	183	"granulocytes: 89.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004962, CAB004963, HPA013859"	Approved									"CAB004962: , CAB004963: , HPA013859: AB_1844758"	"unprognostic (5.31e-4)"	"unprognostic (1.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.36e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-1)"	27.9	0.1	0.2	4.5	1.1	0.2	4.2	0.2	0.3	0.5	2.8	0.2	0.2	1.9	0.2	8.1	0.4	14.4	1.5	2.7	0.3	0.4	0.2	1.7	24.4	1.7	0.5	0.2	3.0	0.2	0.0	6.3	1.5	0.4	0.3	0.9	0.2	1.0	0.2	0.2	2.2	3.7	0.5	0.7	1.1	1.0	1.4	0.4	2.0	0.2	0.2	0.4	1.9	0.2	0.0	0.4	89.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.0	0.0	0.3	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	89.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	1.1	0.2	0.3	0.3	0.4	0.5	0.2	0.4	0.4
C10orf128	Em:AC084727.5	ENSG00000204161	"Chromosome 10 open reading frame 128"	Q5T292	10	49154725-49188585	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 61.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 59.8;HEL: 14.4;K-562: 27.9;U-87 MG: 30.1;U-937: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"eosinophil: 61.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 61.0"	"Low region specificity"	"Detected in many"							HPA058166	Approved									"HPA058166: AB_2683627"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.86e-3)"	"unprognostic (9.13e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (2.86e-5)"	"unprognostic (2.45e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.24e-1)"	21.6	2.6	5.9	12.9	15.0	2.8	19.4	1.7	9.2	13.1	9.9	19.2	4.6	7.0	11.0	10.0	8.6	9.4	14.7	14.2	9.2	6.7	4.1	7.3	21.1	18.7	27.6	6.5	3.7	3.3	10.1	3.0	8.6	15.0	6.8	11.8	9.6	7.6	6.6	6.7	5.6	17.4	16.8	33.7	23.3	6.7	4.7	20.6	1.5	8.0	9.7	18.0	15.3	13.7	9.1	4.6	61.0	0.9	0.0	9.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	59.8	0.0	14.4	0.0	0.0	0.0	0.1	6.4	0.0	0.0	0.0	0.0	0.4	27.9	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	30.1	25.9	0.0	6.0	0.9	61.0	5.5	0.3	9.1	9.1	3.5	5.4	4.6	2.8	0.2	1.6	4.5	0.0	0.1	0.1	2.7	2.3	5.9	15.0	1.7	9.2	9.2	6.7	27.6	6.5	15.0	20.6
CAT		ENSG00000121691	Catalase	P04040	11	34438925-34472062	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 258.3;liver: 184.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 75.2;THP-1: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	13	"eosinophil: 258.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 258.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001515, HPA051282, HPA055838"	Enhanced		Enhanced	Vesicles		960000000	960000000	Vesicles		"CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937"	"unprognostic (3.62e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.80e-3)"	"prognostic favourable (9.67e-4)"	"unprognostic (9.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.77e-2)"	"prognostic favourable (1.96e-8)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.59e-3)"	70.0	33.0	9.4	10.1	9.6	54.2	36.1	3.1	7.7	15.3	26.6	18.6	15.7	22.2	13.5	9.5	14.8	14.2	19.0	22.4	10.7	5.2	50.4	184.8	26.1	21.3	14.5	6.0	11.0	24.7	7.1	5.0	16.4	10.2	23.2	11.3	11.4	14.5	13.2	27.8	19.7	29.2	11.6	11.3	17.9	15.9	6.2	11.6	23.4	41.7	14.9	11.5	20.4	24.9	7.6	19.9	258.3	17.5	5.5	5.0	17.8	6.1	6.8	5.0	7.8	48.4	21.1	10.6	7.8	9.9	8.8	9.7	3.8	6.2	15.2	7.6	15.5	14.7	8.4	8.5	9.8	13.2	7.7	12.8	7.3	21.9	5.7	75.2	6.4	11.3	5.9	2.6	1.0	10.6	26.5	6.3	11.1	5.8	15.4	13.4	0.0	16.6	10.9	23.8	12.4	24.1	23.3	2.6	4.0	8.8	14.2	11.6	20.3	62.8	7.5	5.3	5.2	13.2	4.6	5.1	2.9	3.2	10.4	51.8	3.8	12.5	17.5	258.3	3.2	14.7	3.8	7.6	3.8	3.6	19.9	6.8	3.8	4.0	17.1	5.5	15.5	13.4	5.0	17.8	9.4	9.6	3.1	7.7	10.7	5.2	14.5	6.0	10.2	11.6
CCL23	"Ckb-8, CKb8, MIP-3, MPIF-1, SCYA23"	ENSG00000274736	"C-C motif chemokine ligand 23"	P55773	17	36013056-36017968	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.3"	"Group enriched"	"Detected in some"	4	"HEL: 12.6;THP-1: 26.9"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	173	"eosinophil: 50.3"	"Lineage enriched"	"Detected in single"	173	"granulocytes: 50.3"									HPA042015	Uncertain				"Secreted to blood"	57000	57000			"HPA042015: AB_10794039"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.05e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.95e-1)"	5.8	0.5	0.0	13.1	0.0	2.1	3.7	0.0	0.5	2.1	2.0	0.0	1.0	0.0	1.8	3.0	1.3	1.5	2.2	4.6	0.0		3.0	5.9	7.9	8.0	0.3	0.0	1.2	0.0	0.0	0.5	1.5	0.2	1.7	7.2	0.7	0.0	1.1	0.5	0.4	1.0	8.4	0.0	2.0	0.0	0.1	0.0	0.4	1.1	0.6	0.5	3.0	0.0	0.2	0.1	50.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	1.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.2	0.2	50.3	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0										
CCL4L2		ENSG00000276070	"C-C motif chemokine ligand 4 like 2"	Q8NHW4	17	36210924-36212878	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 41.8;bone marrow: 18.7;lung: 15.2"	"Group enriched"	"Detected in some"	4	"Daudi: 5.6;HMC-1: 8.0;U-266/70: 12.4"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in many"	7	"eosinophil: 41.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 41.8"														"Secreted to blood"						"unprognostic (1.79e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.99e-3)"	0.8	2.4	0.0	4.5	0.6	18.7	8.0	0.3	4.6	0.9	0.4	2.3	0.0	0.6	0.3	0.3	0.1	0.0	4.5	2.1	0.0		0.7	5.0	15.2	8.1	0.6	0.3	0.1	0.1	1.0	0.0	1.0	0.5	0.7	0.8	1.0	1.6	0.0	0.0	0.0	0.5	0.5	0.0	2.6	0.0	0.4	0.4	0.3	0.0	0.9	1.8	1.9	0.0	0.0	0.0	41.8	0.1	0.3	5.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.4	1.9	1.0	0.0	0.1	0.0	0.2	0.1	41.8	5.6	0.0	1.3	0.0	0.2	3.2	0.0	0.0	0.0	3.3	6.3	0.3	0.0	0.0	0.0	1.5										
CYSLTR2	"CysLT(2), CYSLT2R"	ENSG00000152207	"Cysteinyl leukotriene receptor 2"	Q9NS75	13	48653711-48711226	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 37.2;ductus deferens: 25.1;placenta: 22.6;seminal vesicle: 22.4"	"Cell line enriched"	"Detected in single"	77	"HDLM-2: 43.7"	"Group enriched"	"Detected in many"	6	"melanoma: 1.8;renal cancer: 6.6;thyroid cancer: 7.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	12	"eosinophil: 37.2"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 37.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA046528	Uncertain									"HPA046528: AB_2679687"	"unprognostic (9.83e-3)"	"unprognostic (2.72e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.88e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.18e-2)"	2.0	11.4	3.4	3.9	4.2	0.7	1.0	1.6	8.0	0.9	1.0	1.1	25.1	2.1	1.3	1.7	0.7	3.4	1.6	11.5	4.1	3.4	1.8	1.0	1.5	4.4	3.3	1.5	5.4	0.5	0.7	2.3	22.6	3.7	3.4	1.1	2.9	0.7	22.4	0.5	1.3	2.5	0.7	2.3	6.9	1.1	1.0	2.9	1.0	1.1	0.5	1.5	1.0	1.2	0.0	0.9	37.2	3.2	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	1.0	37.2	0.2	3.2	0.0	0.0	0.4	0.0	0.9	0.0	0.5	0.1	0.1	0.4	2.0	0.0	0.3	0.4	3.4	4.2	1.6	8.0	4.1	3.4	3.3	1.5	3.7	2.9
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928444	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;placenta: 33.2"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 35.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	17	"eosinophil: 77.7"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 77.7"	"Region enriched"	"Detected in single"	13	"basal ganglia: 30.5"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol				Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favourable (5.27e-4)"	"prognostic favourable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	8.7	0.2	0.9	11.2	0.9	0.0	1.4	0.9	0.9	4.0	1.5	0.9	0.9	2.6	2.6	0.9	1.2	0.6	1.3	1.0	0.9	0.0	0.9	0.9	16.8	14.1	0.9	0.9	0.9	0.9	0.0	0.9	33.2	0.9	1.6	2.1	1.9	0.9	0.9	2.5	0.3	5.9	0.9	2.0	6.2	2.2	0.9	0.9	0.9	7.2	0.9	8.9	2.3	0.9	0.0	4.6	77.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.4	2.5	0.1	0.3	0.0	35.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.0	0.0	0.1	0.0	0.1	0.0	4.5	0.1	77.7	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9
IFNA2	"IFN-alphaA, IFNA"	ENSG00000188379	"Interferon alpha 2"	P01563	9	21384254-21385388	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.6;brain: 1.3;lymphoid tissue: 1.1"	"Cell line enriched"	"Detected in single"	11	"HeLa: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	17	"eosinophil: 1.6"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.6"									HPA047557	Uncertain				"Secreted to blood"					"HPA047557: AB_2680087"																		0.1	0.0	0.8	0.1	1.3	0.8	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.0	0.4	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.4	1.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.3	0.4	1.0	0.4	0.6	0.1	0.1	0.1
IL34	"C16orf77, IL-34, MGC34647"	ENSG00000157368	"Interleukin 34"	Q6ZMJ4	16	70579895-70660682	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 65.1;skin 1: 31.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.7;Hep G2: 4.4;HSkMC: 4.2;NTERA-2: 9.3;U-138 MG: 6.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	12	"eosinophil: 15.9"	"Lineage enriched"	"Detected in single"	160	"granulocytes: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"						"unprognostic (3.76e-3)"	"prognostic favourable (7.41e-4)"	"unprognostic (5.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-2)"	"prognostic favourable (9.69e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.83e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavourable (3.52e-8)"	"unprognostic (6.47e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.37e-2)"	3.3	10.8	13.4	3.3	13.1	0.6	5.3	5.4	17.7	3.8	2.7	2.7	2.7	4.6	2.2	1.8	10.1	2.8	4.9	3.4	8.6	6.6	2.6	1.6	7.6	5.6	3.9	9.5	1.6	1.5	1.5	5.5	0.9	4.8	2.6	2.2	9.8	6.7	3.4	3.4	31.9	5.1	2.3	1.7	65.1	1.9	2.7	3.0	0.3	2.3	5.0	4.3	3.7	6.1	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.4	3.7	0.4	0.2	3.3	0.3	0.3	0.7	0.1	0.0	0.5	0.5	0.1	0.1	0.1	0.3	0.0	0.2	0.1	0.0	4.4	1.6	0.0	2.8	4.2	0.2	0.4	0.0	0.8	0.0	0.0	1.1	0.0	0.1	0.1	9.3	0.0	0.2	3.1	0.0	0.0	0.0	0.3	0.8	0.2	0.3	0.1	0.0	0.0	0.0	6.1	0.3	0.3	0.4	0.4	0.0	0.0	0.7	1.8	0.1	1.3	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	13.1	5.4	17.7	8.6	6.6	3.9	9.5	4.8	3.0
MYCT1	"FLJ21269, MTLC"	ENSG00000120279	"MYC target 1"	Q8N699	6	152697895-152724567	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 45.9;TIME: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	39	"eosinophil: 20.4"	"Lineage enriched"	"Detected in single"	190	"granulocytes: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047992			Supported	Nucleoplasm,Vesicles		69000	69000	Nucleoplasm	Vesicles	"HPA047992: "	"unprognostic (2.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.64e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavourable (4.73e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.36e-2)"	37.3	3.1	4.1	4.4	6.3	1.1	27.5	3.0	7.7	16.2	8.4	1.5	5.2	3.1	14.5	9.4	14.4	6.8	9.1	17.2	5.1	4.2	6.9	11.1	24.1	4.9	5.8	1.9	8.2	2.5	3.4	2.7	17.4	6.6	8.8	5.3	8.3	4.0	3.7	14.2	4.8	5.5	10.8	5.4	39.4	4.6	7.7	5.2	0.6	12.5	11.0	2.8	17.0	12.3	0.1	0.0	20.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	45.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.2	0.2	0.5	0.0	0.4	0.0	5.7	0.0	0.0	0.0	0.4	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	4.1	6.3	3.0	7.7	5.1	4.2	5.8	1.9	6.6	5.2
PCDH17	"PCDH68, PCH68"	ENSG00000118946	"Protocadherin 17"	O14917	13	57631810-57729311	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2;lymphoid tissue: 32.7"	"Cell line enhanced"	"Detected in some"		"AF22: 15.8;HEK 293: 9.9;U-87 MG: 6.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026817	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		31000	31000	Cytosol	"Vesicles, Plasma membrane"	"HPA026817: AB_1855044"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.26e-4)"	"unprognostic (3.56e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.31e-5)"	"unprognostic (1.07e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.40e-2)"	2.0	2.4	8.0	2.1	11.2	0.3	0.9	4.6	18.2	2.9	1.2	6.2	0.3	1.1	2.6	1.3	1.7	2.5	3.6	2.3	6.5	12.1	1.6	1.4	13.5	0.9	7.4	4.8	0.8	6.2	2.0	1.0	4.7	4.4	1.2	1.2	1.1	1.0	1.1	1.8	0.6	0.7	2.6	4.4	32.7	1.8	8.9	7.7	0.0	3.4	0.4	0.8	3.4	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	2.7	0.0	0.0	1.8	0.0	0.0	0.0	9.9	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.4	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.4	0.0	1.0	0.0	0.0	0.0	6.0	0.0	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	11.2	4.6	7.8	6.5	12.1	7.4	4.8	4.4	7.7
PIK3R6	"C17orf38, FLJ34500, HsT41028, p87PIKAP"	ENSG00000276231	"Phosphoinositide-3-kinase regulatory subunit 6"	Q5UE93	17	8802723-8867677	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.1;lymphoid tissue: 12.2"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 57.5"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in many"	4	"eosinophil: 32.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023077	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"				"Nucleoplasm, Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA023077: AB_1854909"	"unprognostic (4.29e-2)"	"unprognostic (8.56e-3)"	"unprognostic (9.39e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (2.29e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (1.50e-6)"	"unprognostic (3.45e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.98e-2)"	2.2	0.0	2.1	12.2	5.4	5.3	1.0	0.0	3.7	1.5	1.9	2.5	1.4	3.5	2.6	2.3	1.2	0.4	6.6	2.6	3.1		0.0	0.6	3.4	4.4	2.5	0.0	0.3	0.8	0.3	0.0	1.4	3.2	2.4	1.5	1.4	0.9	0.7	1.0	1.8	5.2	2.2	3.1	6.3	2.3	1.1	2.7	6.9	0.0	0.8	6.4	3.0	3.3	1.3	4.9	32.1	4.3	0.5	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	7.3	0.0	0.0	0.0	0.0	57.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	7.7	3.4	32.1	0.2	4.3	0.2	1.3	0.0	0.1	4.9	0.1	0.0	0.1	0.5	0.5	3.3	0.0	0.0	1.4										
PPP1R18	"KIAA1949, phostensin"	ENSG00000146112	"Protein phosphatase 1 regulatory subunit 18"	Q6NYC8	6	30676389-30687895	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 34.6;U-937: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"eosinophil: 54.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 54.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044745, HPA051000"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA044745: AB_2679070, HPA051000: AB_2681304"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (4.71e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavourable (1.11e-16)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.33e-2)"	"unprognostic (4.76e-2)"	17.2	7.1	5.6	24.7	7.9	34.0	16.1	1.7	4.7	12.6	15.9	6.2	4.6	5.3	17.5	7.3	11.5	10.9	13.9	10.1	6.5	3.4	6.1	8.3	20.2	44.9	7.2	1.8	14.9	4.0	2.3	2.9	13.3	6.0	11.2	3.7	7.3	7.9	6.1	6.6	9.5	11.3	13.9	9.8	37.4	9.1	4.9	6.2	48.2	7.8	7.8	23.6	18.2	18.0	4.2	3.4	54.5	4.1	10.2	11.9	5.2	9.9	1.6	5.9	7.2	4.3	11.5	0.2	5.9	6.9	5.3	3.6	1.2	2.0	9.7	5.4	10.4	6.6	2.9	6.5	2.7	8.1	0.6	23.3	2.9	1.2	3.4	6.1	34.6	7.0	7.6	13.0	11.7	4.2	4.3	4.9	6.2	1.0	8.6	12.0	0.0	0.4	27.5	5.2	7.9	3.1	0.6	0.4	2.0	5.5	2.1	11.0	1.6	8.3	14.1	20.8	5.3	0.0	14.7	1.8	9.5	12.0	6.0	36.0	24.2	8.1	2.8	54.5	11.7	4.1	8.5	3.1	5.7	11.9	1.8	4.2	4.7	9.0	13.2	10.2	3.0	3.4	9.4	5.2	5.6	7.9	1.7	4.7	6.5	3.4	7.2	1.8	6.0	6.2
PYROXD2	"C10orf33, FLJ23849"	ENSG00000119943	"Pyridine nucleotide-disulphide oxidoreductase domain 2"	Q8N2H3	10	98383565-98415184	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.8"	"Cell line enhanced"	"Detected in many"		"U-937: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 50.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 50.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037566, HPA037567, HPA067394"	Uncertain		Approved	Mitochondria				Mitochondria		"HPA037566: AB_10670385, HPA037567: AB_2675550, HPA067394: AB_2685832"	"unprognostic (2.35e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic favourable (3.37e-4)"	11.0	15.5	5.1	9.0	7.0	2.7	9.2	2.6	6.3	12.2	6.5	12.0	14.2	2.5	8.3	15.5	4.1	11.6	13.1	9.5	5.3	3.8	6.7	11.7	8.6	2.9	12.6	3.0	11.5	4.3	7.5	6.0	5.0	9.6	12.9	5.8	12.5	26.9	11.3	9.6	3.2	4.1	12.2	8.1	5.2	5.5	3.7	10.7	4.3	9.2	2.3	3.0	11.9	6.9	0.0	0.5	50.8	0.0	11.3	1.8	0.4	2.4	6.1	3.4	0.1	5.4	10.9	1.3	4.0	12.4	2.3	4.3	0.0	8.5	0.0	7.2	4.2	1.2	1.0	1.3	2.3	0.2	1.0	4.9	10.0	0.5	7.0	0.0	11.4	6.4	1.8	1.8	2.2	1.7	0.1	0.1	3.4	7.5	0.1	11.6	1.0	2.1	1.5	1.3	0.1	3.3	3.7	0.2	0.1	4.3	0.5	3.0	3.5	5.5	2.3	0.0	2.6	0.7	3.9	0.8	0.5	0.0	4.1	21.4	0.3	1.1	0.0	50.8	1.8	0.0	0.4	0.0	0.6	1.5	0.5	0.0	0.3	1.1	0.1	11.3	0.0	0.1	0.1	0.4	5.1	7.0	2.6	6.3	5.3	3.8	12.6	3.0	9.6	10.7
SLC29A1	ENT1	ENSG00000112759	"Solute carrier family 29 member 1 (Augustine blood group)"	Q99808	6	44219505-44234151	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 117.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	25	"eosinophil: 117.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 117.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012384	Approved									"HPA012384: AB_1857073"	"unprognostic (1.82e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.76e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (2.96e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.34e-1)"	42.9	40.9	5.8	9.4	9.6	17.9	57.2	10.4	15.2	21.2	35.8	5.9	6.9	5.2	19.8	11.7	22.8	14.9	24.4	46.8	5.4	6.4	14.7	23.2	15.3	14.4	5.5	8.4	12.5	35.8	8.7	15.2	23.2	9.8	21.4	7.4	18.0	15.7	8.4	53.0	23.8	12.4	39.0	5.3	11.4	33.0	8.8	4.8	53.9	18.8	17.2	11.1	28.7	20.7	0.5	4.7	117.2	4.5	0.3	0.9	0.7	16.5	16.5	11.8	18.9	18.1	1.7	70.4	12.2	4.8	17.1	11.7	17.9	6.8	33.6	12.3	3.6	20.6	21.0	14.7	10.3	19.1	19.3	29.0	11.4	23.3	2.9	32.6	28.1	2.2	3.7	25.1	8.8	42.8	39.2	19.9	9.3	18.2	26.9	21.9	17.9	11.0	18.0	23.8	40.7	9.9	9.7	15.2	19.6	3.5	11.9	8.6	16.1	20.7	64.8	9.4	15.4	12.7	23.1	13.6	17.6	42.9	5.7	26.7	11.3	1.8	1.4	117.2	0.6	4.5	0.4	0.5	0.3	0.4	0.8	0.3	0.1	0.3	0.2	0.3	3.6	4.7	0.9	0.7	5.8	9.6	10.4	15.2	5.4	6.4	5.5	8.4	9.8	4.8
